Hamilton James C (CIK 1830755) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-24). Recent activity: Sell ARWR (10,000 shares), Sell ARWR (10,000 shares), Buy ARWR (75,000 shares), Sell ARWR (4,625 shares), Sell ARWR (6,090 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 10,000 | $750,000 |
| 2026-03-09 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 10,000 | $641,900 |
| 2026-01-08 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Buy | 75,000 | $0 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 4,625 | $283,235 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 6,090 | $379,285 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 14,792 | $932,044 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 12,711 | $812,868 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 1,200 | $77,388 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 437 | $28,829 |
| 2026-01-05 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 309 | $21,012 |
| 2025-10-03 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 20,000 | $700,000 |
| 2025-09-16 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 15,000 | $450,000 |
| 2025-09-04 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 15,000 | $375,000 |
| 2025-08-15 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 611 | $12,220 |
| 2025-08-15 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | Sell | 9,389 | $187,780 |
Source: SEC Form 4 filings · as of 2026-04-24